Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Labskin develops and commercializes advanced 3D lab-grown human skin equivalents that closely mimic real human skin, including a functional microbiome. These models are used globally by major cosmetics, personal care, and pharmaceutical companies (e.g., Estée Lauder, Unilever, L’Occitane) for product testing, reducing reliance on animal models. Labskin’s platform enables evaluation of product effects on both skin tissue and the skin microbiome, and the company is expanding into ethnically diverse skin models and disease mimics (e.g., acne, atopic dermatitis, psoriasis, eczema, melanoma)[1][3].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Labskin.